File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Dissecting the genomic complexity underlying medulloblastoma

TitleDissecting the genomic complexity underlying medulloblastoma
Authors
Issue Date2012
Citation
Nature, 2012, v. 488, n. 7409, p. 100-105 How to Cite?
AbstractMedulloblastoma is an aggressively growing tumour, arising in the cerebellum or medulla/brain stem. It is the most common malignant brain tumour in children, and shows tremendous biological and clinical heterogeneity. Despite recent treatment advances, approximately 40% of children experience tumour recurrence, and 30% will die from their disease. Those who survive often have a significantly reduced quality of life. Four tumour subgroups with distinct clinical, biological and genetic profiles are currently identified. WNT tumours, showing activated wingless pathway signalling, carry a favourable prognosis under current treatment regimens. SHH tumours show hedgehog pathway activation, and have an intermediate prognosis. Group 3 and 4 tumours are molecularly less well characterized, and also present the greatest clinical challenges. The full repertoire of genetic events driving this distinction, however, remains unclear. Here we describe an integrative deep-sequencing analysis of 125 tumour-normal pairs, conducted as part of the International Cancer Genome Consortium (ICGC) PedBrain Tumor Project. Tetraploidy was identified as a frequent early event in Group 3 and 4 tumours, and a positive correlation between patient age and mutation rate was observed. Several recurrent mutations were identified, both in known medulloblastoma-related genes (CTNNB1, PTCH1, MLL2, SMARCA4) and in genes not previously linked to this tumour (DDX3X, CTDNEP1, KDM6A, TBR1), often in subgroup-specific patterns. RNA sequencing confirmed these alterations, and revealed the expression of what are, to our knowledge, the first medulloblastoma fusion genes identified. Chromatin modifiers were frequently altered across all subgroups. These findings enhance our understanding of the genomic complexity and heterogeneity underlying medulloblastoma, and provide several potential targets for new therapeutics, especially for Group 3 and 4 patients. © 2012 Macmillan Publishers Limited. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/313951
ISSN
2023 Impact Factor: 50.5
2023 SCImago Journal Rankings: 18.509
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorJones, David T.W.-
dc.contributor.authorJäger, Natalie-
dc.contributor.authorKool, Marcel-
dc.contributor.authorZichner, Thomas-
dc.contributor.authorHutter, Barbara-
dc.contributor.authorSultan, Marc-
dc.contributor.authorCho, Yoon Jae-
dc.contributor.authorPugh, Trevor J.-
dc.contributor.authorHovestadt, Volker-
dc.contributor.authorStütz, Adrian M.-
dc.contributor.authorRausch, Tobias-
dc.contributor.authorWarnatz, Hans Jörg-
dc.contributor.authorRyzhova, Marina-
dc.contributor.authorBender, Sebastian-
dc.contributor.authorSturm, Dominik-
dc.contributor.authorPleier, Sabrina-
dc.contributor.authorCin, Huriye-
dc.contributor.authorPfaff, Elke-
dc.contributor.authorSieber, Laura-
dc.contributor.authorWittmann, Andrea-
dc.contributor.authorRemke, Marc-
dc.contributor.authorWitt, Hendrik-
dc.contributor.authorHutter, Sonja-
dc.contributor.authorTzaridis, Theophilos-
dc.contributor.authorWeischenfeldt, Joachim-
dc.contributor.authorRaeder, Benjamin-
dc.contributor.authorAvci, Meryem-
dc.contributor.authorAmstislavskiy, Vyacheslav-
dc.contributor.authorZapatka, Marc-
dc.contributor.authorWeber, Ursula D.-
dc.contributor.authorWang, Qi-
dc.contributor.authorLasitschka, Bärbel-
dc.contributor.authorBartholomae, Cynthia C.-
dc.contributor.authorSchmidt, Manfred-
dc.contributor.authorvon Kalle, Christof-
dc.contributor.authorAst, Volker-
dc.contributor.authorLawerenz, Chris-
dc.contributor.authorEils, Jürgen-
dc.contributor.authorKabbe, Rolf-
dc.contributor.authorBenes, Vladimir-
dc.contributor.authorvan Sluis, Peter-
dc.contributor.authorKoster, Jan-
dc.contributor.authorVolckmann, Richard-
dc.contributor.authorShih, David-
dc.contributor.authorBetts, Matthew J.-
dc.contributor.authorRussell, Robert B.-
dc.contributor.authorCoco, Simona-
dc.contributor.authorTonini, Gian Paolo-
dc.contributor.authorSchüller, Ulrich-
dc.contributor.authorHans, Volkmar-
dc.contributor.authorGraf, Norbert-
dc.contributor.authorKim, Yoo Jin-
dc.contributor.authorMonoranu, Camelia-
dc.contributor.authorRoggendorf, Wolfgang-
dc.contributor.authorUnterberg, Andreas-
dc.contributor.authorHerold-Mende, Christel-
dc.contributor.authorMilde, Till-
dc.contributor.authorKulozik, Andreas E.-
dc.contributor.authorvon Deimling, Andreas-
dc.contributor.authorWitt, Olaf-
dc.contributor.authorMaass, Eberhard-
dc.contributor.authorRössler, Jochen-
dc.contributor.authorEbinger, Martin-
dc.contributor.authorSchuhmann, Martin U.-
dc.contributor.authorFrühwald, Michael C.-
dc.contributor.authorHasselblatt, Martin-
dc.contributor.authorJabado, Nada-
dc.contributor.authorRutkowski, Stefan-
dc.contributor.authorvon Bueren, André O.-
dc.contributor.authorWilliamson, Dan-
dc.contributor.authorClifford, Steven C.-
dc.contributor.authorMc Cabe, Martin G.-
dc.contributor.authorCollins, V. Peter-
dc.contributor.authorWolf, Stephan-
dc.contributor.authorWiemann, Stefan-
dc.contributor.authorLehrach, Hans-
dc.contributor.authorBrors, Benedikt-
dc.contributor.authorScheurlen, Wolfram-
dc.contributor.authorFelsberg, Jörg-
dc.contributor.authorReifenberger, Guido-
dc.contributor.authorNorthcott, Paul A.-
dc.contributor.authorTaylor, Michael D.-
dc.contributor.authorMeyerson, Matthew-
dc.contributor.authorPomeroy, Scott L.-
dc.contributor.authorYaspo, Marie Laure-
dc.contributor.authorKorbel, Jan O.-
dc.contributor.authorKorshunov, Andrey-
dc.contributor.authorEils, Roland-
dc.contributor.authorPfister, Stefan M.-
dc.contributor.authorLichter, Peter-
dc.date.accessioned2022-07-06T11:28:34Z-
dc.date.available2022-07-06T11:28:34Z-
dc.date.issued2012-
dc.identifier.citationNature, 2012, v. 488, n. 7409, p. 100-105-
dc.identifier.issn0028-0836-
dc.identifier.urihttp://hdl.handle.net/10722/313951-
dc.description.abstractMedulloblastoma is an aggressively growing tumour, arising in the cerebellum or medulla/brain stem. It is the most common malignant brain tumour in children, and shows tremendous biological and clinical heterogeneity. Despite recent treatment advances, approximately 40% of children experience tumour recurrence, and 30% will die from their disease. Those who survive often have a significantly reduced quality of life. Four tumour subgroups with distinct clinical, biological and genetic profiles are currently identified. WNT tumours, showing activated wingless pathway signalling, carry a favourable prognosis under current treatment regimens. SHH tumours show hedgehog pathway activation, and have an intermediate prognosis. Group 3 and 4 tumours are molecularly less well characterized, and also present the greatest clinical challenges. The full repertoire of genetic events driving this distinction, however, remains unclear. Here we describe an integrative deep-sequencing analysis of 125 tumour-normal pairs, conducted as part of the International Cancer Genome Consortium (ICGC) PedBrain Tumor Project. Tetraploidy was identified as a frequent early event in Group 3 and 4 tumours, and a positive correlation between patient age and mutation rate was observed. Several recurrent mutations were identified, both in known medulloblastoma-related genes (CTNNB1, PTCH1, MLL2, SMARCA4) and in genes not previously linked to this tumour (DDX3X, CTDNEP1, KDM6A, TBR1), often in subgroup-specific patterns. RNA sequencing confirmed these alterations, and revealed the expression of what are, to our knowledge, the first medulloblastoma fusion genes identified. Chromatin modifiers were frequently altered across all subgroups. These findings enhance our understanding of the genomic complexity and heterogeneity underlying medulloblastoma, and provide several potential targets for new therapeutics, especially for Group 3 and 4 patients. © 2012 Macmillan Publishers Limited. All rights reserved.-
dc.languageeng-
dc.relation.ispartofNature-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleDissecting the genomic complexity underlying medulloblastoma-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1038/nature11284-
dc.identifier.pmid22832583-
dc.identifier.pmcidPMC3662966-
dc.identifier.scopuseid_2-s2.0-84864419974-
dc.identifier.volume488-
dc.identifier.issue7409-
dc.identifier.spage100-
dc.identifier.epage105-
dc.identifier.isiWOS:000307010700041-
dc.identifier.f1000717962611-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats